HLN vs. NSIS-B.CO

Last updated Apr 2, 2026

Compare and contrast key facts about Haleon plc (HLN) and Novozymes A/S (NSIS-B.CO).

Performance

HLN vs. NSIS-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Haleon plc (HLN) and Novozymes A/S (NSIS-B.CO). The values are adjusted to include any dividend payments, if applicable.

HLN vs. NSIS-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
HLN Haleon plc	-1.38%	7.84%	17.99%	4.21%	7.96%
NSIS-B.CO Novozymes A/S	-5.30%	14.60%	4.23%	12.33%	-17.59%

Different Trading Currencies

HLN is traded in USD, while NSIS-B.CO is traded in DKK. To make them comparable, the NSIS-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, HLN achieves a -1.38% return, which is significantly higher than NSIS-B.CO's -5.30% return.

HLN

• 1D: -0.40%
• 1M: -8.28%
• YTD: -1.38%
• 6M: 10.65%
• 1Y: -0.34%
• 3Y*: 8.45%
• 5Y*: —
• 10Y*: —

NSIS-B.CO

• 1D: 1.49%
• 1M: 6.44%
• YTD: -5.30%
• 6M: -0.67%
• 1Y: 5.53%
• 3Y*: 7.35%
• 5Y*: 0.30%
• 10Y*: 4.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HLN vs. NSIS-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HLN

HLN Risk / Return Rank: 36
HLN Sharpe Ratio Rank: 39
HLN Sortino Ratio Rank: 32
HLN Omega Ratio Rank: 32
HLN Calmar Ratio Rank: 39
HLN Martin Ratio Rank: 39

NSIS-B.CO

NSIS-B.CO Risk / Return Rank: 35
NSIS-B.CO Sharpe Ratio Rank: 37
NSIS-B.CO Sortino Ratio Rank: 31
NSIS-B.CO Omega Ratio Rank: 31
NSIS-B.CO Calmar Ratio Rank: 39
NSIS-B.CO Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HLN vs. NSIS-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Haleon plc (HLN) and Novozymes A/S (NSIS-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HLN	NSIS-B.CO	Difference
Sharpe ratio Return per unit of total volatility	-0.01	0.21	-0.23
Sortino ratio Return per unit of downside risk	0.14	0.50	-0.36
Omega ratio Gain probability vs. loss probability	1.02	1.06	-0.04
Calmar ratio Return relative to maximum drawdown	-0.06	0.22	-0.28
Martin ratio Return relative to average drawdown	-0.11	0.43	-0.54
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HLN vs. NSIS-B.CO - Sharpe Ratio Comparison

The current HLN Sharpe Ratio is -0.01, which is lower than the NSIS-B.CO Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of HLN and NSIS-B.CO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HLN	NSIS-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.01	0.21	-0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.01	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.17	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.24	+0.17

Correlation

The correlation between HLN and NSIS-B.CO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HLN vs. NSIS-B.CO - Dividend Comparison

HLN's dividend yield for the trailing twelve months is around 1.76%, less than NSIS-B.CO's 2.76% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HLN Haleon plc	1.76%	1.73%	1.65%	1.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NSIS-B.CO Novozymes A/S	2.76%	1.58%	0.98%	2.75%	1.56%	0.98%	1.50%	1.53%	1.55%	1.13%	1.44%	0.91%

Drawdowns

HLN vs. NSIS-B.CO - Drawdown Comparison

The maximum HLN drawdown since its inception was -24.83%, smaller than the maximum NSIS-B.CO drawdown of -56.95%. Use the drawdown chart below to compare losses from any high point for HLN and NSIS-B.CO.

Drawdown Indicators

	HLN	NSIS-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-24.83%	-52.31%	+27.48%
Max Drawdown (1Y) Largest decline over 1 year	-23.11%	-29.44%	+6.33%
Max Drawdown (5Y) Largest decline over 5 years	—	-46.90%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-46.90%	—
Current Drawdown Current decline from peak	-12.09%	-21.70%	+9.61%
Average Drawdown Average peak-to-trough decline	-7.99%	-13.45%	+5.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.54%	15.64%	-3.10%

Volatility

HLN vs. NSIS-B.CO - Volatility Comparison

The current volatility for Haleon plc (HLN) is 7.14%, while Novozymes A/S (NSIS-B.CO) has a volatility of 7.68%. This indicates that HLN experiences smaller price fluctuations and is considered to be less risky than NSIS-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HLN	NSIS-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.14%	7.68%	-0.54%
Volatility (6M) Calculated over the trailing 6-month period	16.43%	18.81%	-2.38%
Volatility (1Y) Calculated over the trailing 1-year period	23.67%	27.32%	-3.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.04%	28.48%	-4.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.04%	27.29%	-3.25%

Financials